PurposeHaemophilus in uenzae is a common cause of mucosal infections that warrants accurate surveillance.We aimed to assess the prevalence of the species in clinical specimens, and characterise population structure and resistance to aminopenicillins by whole genome sequencing.
MethodsWe assessed the point prevalence by entering the database records of one day in Denmark, and examined the genome sequences of nationwide, collected isolates from the same day.
ResultsThe prevalence of H. in uenzae in clinical samples on the 10 th of January 2018 was 1.78 per 100,000 person-days (all samples), and 2.47 per 1,000 hospital bed-days (hospital samples). Of 2,009 bacteria deemed clinically relevant and collected in a concerted action by the Danish departments of clinical microbiology, 62 (3.1%) were H. in uenzae. All 62 isolates belonged to phylogenetic group I and were unencapsulated. Three strains from separate Danish regions had identical core genome sequences, but a small number of intergenic mutations testi ed to circulating clones, rather than individual cases of patient-to-patient transmission. The TEM-1 β-lactamase gene was present in 24 strains, while 13 strains were genetically categorised as ampicillin-resistant due to substitutions in penicillin-binding protein 3; shared patterns of amino acid substitutions in unrelated strains indicated putative lateral transfer of chromosomal resistance.
ConclusionsCirculating clones of H. in uenzae are frequent, and host factors, rather than direct transmission of epidemic strains, may be the primary cause of infection. The bleak presence of ampicillin resistance revealed by sequencing of point prevalence strains underscores the necessity for close examination of testing methods.